Skip to main content
. 2015 Jul 31;5(7):e331. doi: 10.1038/bcj.2015.59

Figure 2.

Figure 2

Kaplan–Meier survival curves for OS and DFS in a total of 363 AML patients (a, b), 36 patients with unfavorable-risk cytogenetics (c, d) and 28 patients with complex karyotype (e, f) who received standard intensive chemotherapy.